GABAC receptor ion channels

被引：50

作者：

Chebib, M ^{[1
]}

机构：

[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia

来源：

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2004年 / 31卷 / 11期

关键词：

GABA(C) receptors; ligand-gated ion channels; site-directed mutagenesis; structure-activity relationship studies;

D O I：

10.1111/j.1440-1681.2004.04083.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

1. The present review gives an overview of studies conducted on GABA(C) receptors over the past 10 years since the author started at the University of Sydney. It concentrates on the structure-activity relationship profiles of the receptor and how these studies were used to: (i) develop selective GABA(C) receptor ligands; and (ii) understand the impact of amino acid changes on GABA(C) receptor pharmacology and function. 2. Structure-activity relationship studies involving variations of both ligands and their receptor targets are vital to the discovery of drugs that interact selectively with particular native and mutant receptor subtypes. Such agents may be useful for treating anxiety, depression, epilepsy and memory related disorders, such as Alzheimer's disease.

引用

收藏

页码：800 / 804

页数：5

相关论文

共 37 条

[1] STRUCTURE-ACTIVITY STUDIES ON THE ACTIVITY OF A SERIES OF CYCLOPENTANE GABA ANALOGS ON GABA-A RECEPTORS AND GABA UPTAKE [J].

ALLAN, RD ;

DICKENSON, HW ;

FONG, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 122 (03) :339-348

[2] Study of a GABAc receptor antagonist on sleep-waking behavior in rats [J].

Arnaud, C ;

Gauthier, P ;

Gottesmann, C .

PSYCHOPHARMACOLOGY, 2001, 154 (04) :415-419

[3] Molecular and electrophysiological evidence for a GABAC receptor in thyrotropin-secreting cells [J].

Boue-Grabot, E ;

Taupignon, A ;

Tramu, G ;

Garret, M .

ENDOCRINOLOGY, 2000, 141 (05) :1627-1632

[4] Mutations of the 2′ proline in the M2 domain of the human GABAC ρ1 subunit alter agonist responses [J].

Carland, JE ;

Moore, AM ;

Hanrahan, JR ;

Mewett, KN ;

Duke, RK ;

Johnston, GAR ;

Chebib, M .

NEUROPHARMACOLOGY, 2004, 46 (06) :770-781

[5] GABAc receptor antagonists differentiate between human p1 and p2 receptors expressed in Xenopus oocytes [J].

Chebib, M ;

Mewett, KN ;

Johnston, GAR .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 357 (2-3) :227-234

[6]

Chebib M, 1997, J NEUROCHEM, V68, P786

[7] The effects of cyclopentane and cyclopentene analogues of GABA at recombinant GABAC receptors [J].

Chebib, M ;

Duke, RK ;

Allan, RD ;

Johnston, GAR .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 430 (2-3) :185-192

[8] GABA-activated ligand gated ion channels: Medicinal chemistry and molecular biology [J].

Chebib, M ;

Johnston, GAR .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (08) :1427-1447

[9] ZIP3, a new splice variant of the PKC-ζ-interacting protein family, binds to GABAc receptors, PKC-ζ, and Kvβ2 [J].

Croci, C ;

Brandstätter, JH ;

Enz, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) :6128-6135

[10] (+)- and (-)-cis-2-Aminomethylcyclopropanecarboxy acids show opposite pharmacology at recombinant ρ1 and ρ2 GABAC receptors [J].

Duke, RK ;

Chebib, M ;

Balcar, VJ ;

Allan, RD ;

Mewett, KN ;

Johnston, GAR .

JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2602-2610

← 1 2 3 4 →